ABT270917C00130000
ABT Sep 17 2027 130.00 Call
optionOPRA
EODNov 5, 2026
7.30USD-5.195%(-0.40)17Vol1,433OI
Loading…
Underlying
Underlying Price
$110.10
Type
Call
Strike
130
Expiration
Sep 17, 2027
DTE
314d
Moneyness
OTM
Intrinsic
$0.00
ABT 130 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Nov 6, 2026 | -1d | — | — | 0 | 0 |
| Nov 13, 2026 | 6d | — | — | 0 | 0 |
| Nov 20, 2026 | 13d | $0.33 | +560.00% | 19 | 1,211 |
| Nov 27, 2026 | 20d | — | — | 0 | 0 |
| Dec 4, 2026 | 27d | — | — | 0 | 0 |
| Dec 11, 2026 | 34d | — | — | 0 | 0 |
| Dec 18, 2026 | 41d | $0.35 | -50.00% | 100 | 1,101 |
| Dec 24, 2026 | 47d | — | — | 0 | 0 |
| Jan 15, 2027 | 69d | $0.85 | -30.89% | 134 | 1,608 |
| Feb 19, 2027 | 104d | $1.85 | -21.28% | 399 | 691 |
| Mar 19, 2027 | 132d | $2.25 | -25.00% | 65 | 431 |
| May 21, 2027 | 195d | $4.67 | +110.36% | 265 | 478 |
| Jun 17, 2027 | 222d | $4.73 | -5.40% | 121 | 240 |
| Sep 17, 2027 | 314d | $7.30 | -5.19% | 17 | 1,433 |
| Dec 17, 2027 | 405d | $9.00 | +0.00% | 10 | 10 |
| Jan 21, 2028 | 440d | $9.20 | -12.80% | 9 | 5,462 |
| Mar 17, 2028 | 496d | $11.20 | -5.72% | 2 | 106 |
| Jan 19, 2029 | 804d | $15.30 | +13.33% | 3 | 7 |
ABT Nearby Strikes · Sep 17, 2027
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 100 C | $20.20 | +47.45% | 2 | 9 | ITM |
| 105 C | $19.00 | +22.34% | 4 | 13 | ITM |
| 110 C | $16.30 | +30.61% | 6 | 155 | ITM |
| 115 C | $13.25 | -4.68% | 10 | 57 | OTM |
| 120 C | $11.20 | -2.61% | 6 | 150 | OTM |
| 125 C | $8.50 | -8.11% | 2 | 129 | OTM |
| 130 C | $7.30 | -5.19% | 17 | 1,433 | OTM |
| 135 C | $5.58 | -5.74% | 45 | 89 | OTM |
| 140 C | $5.45 | +3.02% | 1 | 576 | OTM |
| 145 C | $4.00 | +2.56% | 33 | 50 | OTM |
| 150 C | $3.30 | +157.81% | 3 | 95 | OTM |
| 155 C | $1.60 | +60.00% | 50 | 59 | OTM |
| 160 C | — | — | 0 | 0 | OTM |
ABT Profile
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.